Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin II Dose Finding for Anesthesia-Mediated Hypotension
NCT03733145Phase 4Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Oct 2019
- Primary completion
- Mar 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Angiotensin II in anesthesia-induced hypotension, sponsored by Wake Forest University Health Sciences. Started Oct 2019; status: completed.
02
Drugs
Angiotensin II
03
Conditions
anesthesia-induced hypotension
Beyond the preview
Go deeper on NCT03733145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03733145.